TABLE 1.
Diabetes in Pregnancy (US 2014, WHO 2013) | GDM | ||||||||||||||||
US 2014 | Switzerland 2009 | Canada 2013 | Australia 2013 | UK 2008 | France 2011 | Germany 2011 | Austria 2012 | Belgium 2012 | WHO 2013 | ||||||||
Test specifics | 75-g OGTT | IADPSG: (1 step): 75-g OGTT; 1 positive value required | NIH (2 steps): 50-g GCT followed by 100-g OGTT: 2 positive values required | 75-g OGTT, 1 positive value required | 50-g GCT (2 steps) | 75-g OGTT; 1 positive value required (as part of 2-step approach with GCT or as 1 step only, but different threshold) | 75-g OGTT; 1 positive value required | Refer to WHO guidelines | 75-g OGTT; 1 positive value required | 50-g GCT (2 steps) | 75-g OGTT; 1 positive value required | 75-g OGTT; 1 positive value required | VDV-VVOG 2 step: 50-g GCT followed by 100- or 75-g OGTT | GGOLFB 75-g OGTT; 1 positive value required | 75-g OGTT: 1 positive value required | ||
Step 1: 50-g GCT | Step 2: 100-g OGTT* | Step 1: 50-g GCT | Step 2: 100- or 75-g OGTT (2 abnormal values required) | ||||||||||||||
Fasting | ≥126 | ≥92 | — | ≥95a or ≥105b | ≥92 | Non-fasting | 2 steps: ≥95; 1 step: ≥92 | ≥92 | — | ≥92 | — | ≥92 | ≥92 | ≥95 | ≥92 | 92–125: 75-g OGTT | |
1-hour | — | ≥180 | ≥140 | ≥180a or 190b | ≥180 | 140–198: OGTT; >198: GDM | 2 steps: ≥190 1 step: ≥180 | ≥180 | — | — | ≥135 | ≥180 | ≥180 | ≥140 | ≥180 | ≥180 | ≥180 |
2-hour | ≥200 | ≥153 | — | ≥155a or ≥165b | ≥153 | — | 2 steps: ≥162; 1 step: ≥153 | ≥153 | — | ≥153 | — | ≥153 | ≥153 | — | ≥155 | ≥153 | 153–199 |
3-hour | — | — | — | ≥140a or ≥145b | — | — | — | — | — | — | — | — | — | — | ≥140 | — | — |
Random | ≥200 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
GCT, glucose challenge test; GGOLFB, Groupement des Gynécologues Obstétricien de Langue Française de Belgique; IADPSG, International Association of Diabetes and Pregnancy Study Groups; NIH, National Institutes of Health; OGTT, oral glucose tolerance test; UK, United Kingdom; US, United States; VDV, Vlaamse Diabetes Vereniging; VVOG, Vlaamse Vereniging voor Obstetrie en Gynecologie.
This guideline includes two differing sets of diagnostic glucose thresholds, referred to as aCarpenter/Coustan and bNational Diabetes Data Group.